Don't let it get away!
Keep track of the stocks that matter to you.
Help yourself with the Fool's FREE and easy new watchlist service today.
In today's edition of Market Checkup, health-care analysts David Williamson and Max Macaluso take a close look at Merck, a Dow component and one of the biggest players in the pharmaceutical industry. They analyze the highlights from Merck's second-quarter results and examine the company's main vulnerabilities.
One of the best parts of owning big pharma stocks is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.